Cargando…

Controversies in breast cancer: the mammalian target of rapamycin as a target for breast cancer therapy

Detalles Bibliográficos
Autor principal: Di Cosimo, Serena
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797705/
https://www.ncbi.nlm.nih.gov/pubmed/20030877
http://dx.doi.org/10.1186/bcr2444
_version_ 1782175658235920384
author Di Cosimo, Serena
author_facet Di Cosimo, Serena
author_sort Di Cosimo, Serena
collection PubMed
description
format Text
id pubmed-2797705
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27977052009-12-25 Controversies in breast cancer: the mammalian target of rapamycin as a target for breast cancer therapy Di Cosimo, Serena Breast Cancer Res Short Communication BioMed Central 2009 2009-12-18 /pmc/articles/PMC2797705/ /pubmed/20030877 http://dx.doi.org/10.1186/bcr2444 Text en Copyright ©2009 BioMed Central Ltd
spellingShingle Short Communication
Di Cosimo, Serena
Controversies in breast cancer: the mammalian target of rapamycin as a target for breast cancer therapy
title Controversies in breast cancer: the mammalian target of rapamycin as a target for breast cancer therapy
title_full Controversies in breast cancer: the mammalian target of rapamycin as a target for breast cancer therapy
title_fullStr Controversies in breast cancer: the mammalian target of rapamycin as a target for breast cancer therapy
title_full_unstemmed Controversies in breast cancer: the mammalian target of rapamycin as a target for breast cancer therapy
title_short Controversies in breast cancer: the mammalian target of rapamycin as a target for breast cancer therapy
title_sort controversies in breast cancer: the mammalian target of rapamycin as a target for breast cancer therapy
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797705/
https://www.ncbi.nlm.nih.gov/pubmed/20030877
http://dx.doi.org/10.1186/bcr2444
work_keys_str_mv AT dicosimoserena controversiesinbreastcancerthemammaliantargetofrapamycinasatargetforbreastcancertherapy